BIVIGAM®

BIVIGAM is indicated for the treatment of patients with primary humoral immunodeficiency (PI). This includes, but is not limited to, the humoral immune defect in common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

For indications, dosing and other information, please refer to the prescribing information.

BIVIGAM® ‐ Kedrion

Size:
5 gram vial
NDC #:
59730-6502-01
Download:
PI
Size:
10 gram vial
NDC #:
59730-6503-01
Download:
PI